Real-time enrollment status for this head and neck cancer clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 6:41 AM UTC
| NCT Number | NCT06295731 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Head and Neck Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 410 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Inhibrx Biosciences, Inc |
| Last Updated on CT.gov | March 31, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT06295731 is currently active_not_recruiting participants. This clinical trial study for head and neck cancer is not currently accepting new participants at 25 locations across the United States. The study is sponsored by Inhibrx Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06295731 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06295731 was last updated 2 weeks ago (March 31, 2026). HelloStudys verifies this status automatically.